Gratus Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-67,311
Closed -$2.35M 232
2022
Q4
$2.35M Buy
+67,311
New +$2.35M 0.19% 82